Stock RXRX RECURSION PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Delayed Nasdaq
Other stock markets
 03:46:50 2024-05-09 pm EDT 		5-day change 1st Jan Change
8.64 USD +0.58% Intraday chart for Recursion Pharmaceuticals, Inc. -1.93% -12.58%
Apr. 18 Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing MT
Apr. 16 Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Let's move forwardLet's move forward February 15, 2024 at 09:36 am EST
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RXRX Stock
  4. News Recursion Pharmaceuticals, Inc.
  5. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW